High-dose Chemotherapy with Hematopoietic Stem Cell Transplantation is Effective for Nasal and Nasal-type CD56⁺ Natural Killer Cell Lymphomas

References

• Kanavaros P., Lescs M.-C., Brière J., Divine M., Galateaa F., Joab I., Bosq J., Farcet J.-P., Reyes F., Gaulard P. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–2695
   PubMed Web of Science ®Google Scholar
• Ho F. C.S., Choy D., Loke S. L., Rung I. T.M., Fu K. H., Liang R., Todd D., Khoo R. K.K. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Human Pathology 1990; 21: 1041–1050
   PubMed Web of Science ®Google Scholar
• Emile J.-F., Boulland M.-L., Haioun C., Kanavaros P., Petrella T., Delfau-Larue M.-H., Bensussan A., Farcet J.-P., Gaulard P. CD5 CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87: 1466–1473
   PubMed Web of Science ®Google Scholar
• Jaffe E. S., Chan J. K.C., Su I.-J., Frizzera G., Mori S., Feller A. C., Ho F. C.S. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. American Journal of Surgical Pathology 1996; 20: 103–111
   PubMed Web of Science ®Google Scholar
• Jaffe E. S. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996; 87: 1207–1210
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K.C., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Issacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Diebold J., Flandrin G., Muller-Hermelink H. K., Vardiman J., Lister T. A., Bloomfield C. D. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting—Airlie House, Virginia, November 1997. Journal of Clinical Oncology 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Nakamura S., Suchi T., Koshikawa T., Kitoh K., Kioke K., Komatsu H., Iida S., Kagami Y., Ogura M., Katoh E., Kurita S., Suzuki H., Kobashi Y., Yamabe H., Hirabayashi N., Ueda R., Takahashi T. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. American Journal of Surgical Pathology 1995; 19: 284–296
   PubMed Web of Science ®Google Scholar
• Wong K. F., Chan J. K.C., Ng C. S., Lee K. C., Tsang W. Y.W., Cheung M. M.C. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules and angiocentricity. Human Pathology 1992; 23: 798–804
   PubMed Web of Science ®Google Scholar
• Kern W. F., Spier C. M., Hanneman E. H., Miller T. P., Matzner M., Grogan T. M. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992; 79: 2432–2437
   PubMed Web of Science ®Google Scholar
• Chan J. K.C., Sin V. C., Wong K. F., Ng C. S., Tsang W. Y.W., Chan C. H., Cheung M. M.C., Lau W. H. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501–4513
   PubMed Web of Science ®Google Scholar
• Liang R., Todd D., Chan T. K., Chiu E., Lie A., Kwong Y. L., Choy D., Ho F. C.S. Treatment outcome and prognostic factors for primary nasal lymphoma. Journal of Clinical Oncology 1995; 13: 666–670
   PubMed Web of Science ®Google Scholar
• Kwong Y. L., Chan A. C.L., Liang R., Chiang A. K.S., Chin C. C., Chan C. T.K., Todd D., Ho F. C.S. CD56+ NK lymphomas: clinicopathological features and prognosis. British Journal of Haematology 1997; 97: 821–829
   PubMed Web of Science ®Google Scholar
• Cheung M. M.C., Chan J. K.C., Lau W. H., Foo W., Chan P. T.M., Ng C. S., Ngan R. K.C. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. Journal of Clinical Oncology 1998; 16: 70–77
   PubMed Web of Science ®Google Scholar
• Kim G. E., Cho J. H., Yang W. I., Chung E. J., Suh CO., Park K. R., Hong W. P., Park I. Y., Hahn J. S., Roh J. K., Kim B. S. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. Journal of Clinical Oncology 2000; 18: 54–63
   PubMed Web of Science ®Google Scholar
• Liang R., Chen F., Lee C. K., Kwong Y. L., Chim C. S., Yau C. C., Chiu E. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplantation 1997; 19: 91–93
   PubMed Web of Science ®Google Scholar
• Ohnuma K., Toyoda Y., Nishihira H., Iguchi A., Honda K., Nagao T., Kigasawa H., Tanaka Y., Kikuta H. Aggressive natural killer (NK) cell lymphoma: report of a pediatric case and review of the literature. Leukemia and Lymphoma 1997; 25: 387–392
   PubMed Web of Science ®Google Scholar
• Nawa Y., Takenaka K., Shinagawa K., Deguchi S., Matsumura N., Koyama S., Hiramatus Y., Omoto E., Yoshino T., Harada M. Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation. Bone Marrow Transplantation 1999; 23: 1321–1322
   PubMed Web of Science ®Google Scholar
• Mukai H., Kojima H., Suzukawa K., Hori M., Komeno T., Hasegawa Y., Ninomiya H., Mori N., Nagasawa T. High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma. Leukemia and Lymphoma 1999; 32: 583–588
   PubMed Web of Science ®Google Scholar
• Sasaki M., Matuse K., Takeuchi M., Mitome M., Hirose Y. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation. International Journal of Hematology 2000; 71: 75–78
   PubMed Web of Science ®Google Scholar
• Cheson B. D., Homing S. J., Coiffier B., Shipp M. A., Fisher R. I., Connors J. M., Lister T. A., Vose J., Grillo-López A., Hagenbeek A., Cabanillas F., Klippensten D., Hiddemann W., Castellino R., Harris N. L., Armitage J. O., Carter W., Hoppe R., Canellos G. P. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. Journal of Clinical Oncology 1999; 17: 1244–1253
   PubMed Web of Science ®Google Scholar
• Wilson W. H., Biyant G., Bates S., Fojo A., Wittes R. E., Steinberg S. M., Kohler D. R., Jaffe E. S., Herdt J., Cheson B. D., Chabner B. A. EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. Journal of Clinical Oncology 1993; 11: 1573–1582
   PubMed Web of Science ®Google Scholar
• Drénou B., Lamy T., Amiot L., Fardel O., Caulct-Maugendre S., Sasportes M., Diebold J., Le Prisé P.-Y, Fauchet R. CD3″ C56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood 1997; 89: 2966–2974
   PubMed Web of Science ®Google Scholar
• Teshima T., Miyaji R., Fukuda M., Ohshima K. Bone-marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia. Lancet 1996; 347: 1124
   PubMed Web of Science ®Google Scholar
• Takami A., Nakao S., Yachie A., Kasahara Y., Okumura H., Miura Y., Sugimori N., Zeng W., Wang H., Kotani T., Shiobara S., Matsuda T. Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplantation 1998; 21: 1279–1282
   PubMed Web of Science ®Google Scholar